Media

January 10, 2025: MaaT013 Elicits Durable Responses in Acute Graft-vs-Host Disease – Cancer Network

Date : January 27, 2025

To see the interview click here

January 9, 2025: Microbiome trial boosts MaaT, sets path for EU marketing bid – The Pharma Letter

January 13, 2025: ARES Trial of MaaT013 in Acute GVHD Meets Primary End Point – Targeted Oncology